Skip to main content
Clinical Trials/NL-OMON50896
NL-OMON50896
Recruiting
N/A

The effectivity of lifestyle interventions and prevention in patients with atrial fibrillation referred for ablation; a randomised-controlled trial - Prevention to improve Outcomes after PVI (POP-trial)

Catharina-ziekenhuis0 sites150 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Catharina-ziekenhuis
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with paroxysmal or persistent atrial fibrillation referred for initial
  • catheter ablation
  • Age 18\-75 years
  • The patient should have at least on treatable risk factor (BMI \>\=27 kg/m2,
  • hyperlipidaemia, hypertension, diabetes mellitus with HbA1c \>\=53 mmol/mol,
  • active smoking, or excess alcohol use)
  • Patients are willing and able to use the VitalHealth Engage platform on their
  • own preferred device

Exclusion Criteria

  • Longstanding persistent atrial fibrillation (persistent atrial fibrillation for
  • more than 1 year)
  • Permanent atrial fibrillation
  • Asymptomatic atrial fibrillation
  • Prior ablation
  • Severe valvular heart disease
  • Prior or soon foreseen implantation of cardiac device
  • Acute coronary syndroom \< 3 months before inclusion
  • Unstable heart failure NYHA IV or heart failure necessitating admission \<3
  • months before inclusion

Outcomes

Primary Outcomes

Not specified

Similar Trials